Cargando…

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan

Detalles Bibliográficos
Autores principales:	Ferri, MB, Passos, RH, Knobel, M, Nigri, M, Figueiredo, EJA, Morsch, RD, Silveira, P, Souza, JMA, Perez, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092565/ http://dx.doi.org/10.1186/cc4537

Ejemplares similares

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in compensated chronic heart failure patients treated with levosimendan
por: Figueiredo, EJ de Almeida, et al.
Publicado: (2007)

Correlation of B-type natriuretic peptide and electrocardiographic alteration at presentation and prognosis in patients with non-ST-segment elevation myocardial infarction
por: Nigri, M, et al.
Publicado: (2005)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance
por: Xiangli, Shen, et al.
Publicado: (2021)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes
por: Dencker, Magnus, et al.
Publicado: (2010)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

On-pump versus off-pump coronary artery bypass grafting: relationship between complications and released cytokines after on-pump surgery
por: Nigri, M, et al.
Publicado: (2005)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
por: Suominen, Pertti K
Publicado: (2011)

The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure
por: Korkmaz, Hasan, et al.
Publicado: (2019)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide
por: Rodrigues, Ana Clara Tude, et al.
Publicado: (2013)

The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population
por: Chen, Li Juen, et al.
Publicado: (2016)

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients
por: Kadri, Amer N., et al.
Publicado: (2018)

Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure
por: Meng, Paris, et al.
Publicado: (2018)

Severe hemodynamic compromise, respiratory failure and disseminated skin lesions due to Strongyloides stercoralis
por: Mohovic, T, et al.
Publicado: (2003)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
por: Ding, Jingdong, et al.
Publicado: (2008)

Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services
por: Yii, Eric, et al.
Publicado: (2021)

Early Identification of Decompensated Aortic Regurgitation With Stress Echocardiography
por: Latifi, Ahmad N., et al.
Publicado: (2021)

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2016)

Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Qu, Chao, et al.
Publicado: (2022)

Natriuretic Peptide and Clinical Evaluation in the Diagnosis of Heart Failure Hemodynamic Profile: Comparison with Tissue Doppler Echocardiography
por: de Almeida Junior, Gustavo Luiz Gouvêa, et al.
Publicado: (2018)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients
por: Ruocco, Gaetano, et al.
Publicado: (2021)

The utility of B-type natriuretic peptide in differentiating decompensated heart failure from lung disease in patients presenting to the emergency department with dyspnea
por: Villacorta, H, et al.
Publicado: (2003)

Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
por: Pan, Hai-Yan, et al.
Publicado: (2014)

Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure
por: Yoon, Jae Yong, et al.
Publicado: (2019)

B-type natriuretic peptide/ferritin ratio as a predictor of the risk of developing acute renal injury in acute decompensated heart failure
por: Ceyhun, Gökhan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lhk814pavrumg9ku9gu5o9882